Your browser doesn't support javascript.
loading
College campuses and COVID-19 mitigation: clinical and economic value
Elena Losina; Valia Leifer; Lucia Millham; Christopher Panella; Emily P. Hyle; Amir M. Mohareb; Anne M. Neilan; Andrea L. Ciaranello; Pooyan Kazemian; Kenneth A. Freedberg.
Affiliation
  • Elena Losina; BWH
  • Valia Leifer; Brigham and Women's Hospital
  • Lucia Millham; Massachusetts General Hospital
  • Christopher Panella; Massachusetts General Hospital
  • Emily P. Hyle; Massachusetts General Hospital
  • Amir M. Mohareb; Massachusetts General Hospital
  • Anne M. Neilan; Massachusetts General Hospital
  • Andrea L. Ciaranello; Massachusetts General Hospital
  • Pooyan Kazemian; Case Western Reserve University
  • Kenneth A. Freedberg; Massachusetts General Hospital
Preprint in English | medRxiv | ID: ppmedrxiv-20187062
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
BackgroundDecisions around US college and university operations will affect millions of students and faculty amidst the COVID-19 pandemic. We examined the clinical and economic value of different COVID-19 mitigation strategies on college campuses. MethodsWe used the Clinical and Economic Analysis of COVID-19 interventions (CEACOV) model, a dynamic microsimulation that tracks infections accrued by students and faculty, accounting for community transmissions. Outcomes include infections, $/infection-prevented, and $/quality-adjusted-life-year ($/QALY). Strategies included extensive social distancing (ESD), masks, and routine laboratory tests (RLT). We report results per 5,000 students (1,000 faculty) over one semester (105 days). ResultsMitigation strategies reduced COVID-19 cases among students (faculty) from 3,746 (164) with no mitigation to 493 (28) with ESD and masks, and further to 151 (25) adding RLTq3 among asymptomatic students and faculty. ESD with masks cost $168/infection-prevented ($49,200/QALY) compared to masks alone. Adding RLTq3 ($10/test) cost $8,300/infection-prevented ($2,804,600/QALY). If tests cost $1, RLTq3 led to a favorable cost of $275/infection-prevented ($52,200/QALY). No strategies without masks were cost-effective. ConclusionExtensive social distancing with mandatory mask-wearing could prevent 87% of COVID-19 cases on college campuses and be very cost-effective. Routine laboratory testing would prevent 96% of infections and require low cost tests to be economically attractive.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Prognostic study Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Prognostic study Language: English Year: 2020 Document type: Preprint
...